Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > OMBU Group Invests £3 Million of Growth Capital in Phase Focus: Fourth investment completed in 12 months for new UK Investment Company

Abstract:
Ombu Group ("Ombu") a new, UK investment company, announces that it is investing £3 million of growth capital into nanotech imaging company Phase Focus Ltd. ("Phase Focus" or "the Company").

OMBU Group Invests £3 Million of Growth Capital in Phase Focus: Fourth investment completed in 12 months for new UK Investment Company

Sheffield, UK | Posted on July 4th, 2012

Phase Focus is a UK company, based in Sheffield, that has developed and is now commercialising a revolutionary lensless imaging technology , the Phase Focus Virtual Lens®, that eliminates the need for conventional focussing devices (such as a glass lens) in microscopy and transfers the image-producing step to a computer programme. This process can generate high definition images of an object without the need for the high quality lenses that account for a significant element of the cost of high-performance microscopes, as well as enabling unprecedented clarity and accuracy in the observation and analysis of materials, processes and products.

By eliminating the need for conventional focussing devices, the Virtual Lens enables new applications and novel analytical capabilities in markets as diverse as optical, life sciences and semiconductor process control, and in multiple wavelength regimes - such as visible light, X-ray, electron, and more. By integrating their Virtual Lens Technology into existing products and into new microscopy and imaging instruments via collaborations with leading analytical equipment vendors, the Company can develop a wide range of new analytical tools that can span all aspects of the nanotechnology industry. Ombu's investment will allow Phase Focus to accelerate the commercialisation of its technology across its existing application areas as well as invest in R&D to develop new tools and applications.

The Company is the fourth UK advanced technology company Ombu has backed since its launch in May 2011. Phase Focus, like all of Ombu's companies, is based on world-class UK innovation, has recently broken through into selling its products and services, and will use Ombu's capital and management support to expand rapidly in the UK and overseas.

Commenting on the investment, Stephen Brooke, CEO of Ombu Group said: "Ombu Group is dedicated to backing cutting-edge UK advanced technology companies that have the potential to grow into substantial, durable businesses. This is a fantastic opportunity for us to partner with a company with remarkable technology that has just broken through into its full commercial phase. We had tracked Phase Focus for a few years before now and had always been amazed by the technology, so it is great to be able to back a team we have seen deliver and support them as they seek to grow their business. We really look forward to working closely with Ian, his talented team and Fusion IP along with the company's other existing shareholders to build on the great work they have done over the last few years."

Ian Pykett, CEO of Phase Focus, added: ""Phase Focus has achieved a huge amount with our technology now developed, proven and selling in the market. The opportunities for our technology are enormous so we are incredibly excited about what lies ahead for our company. We only wanted to bring in another partner if we felt they could clearly help us to accelerate our specific growth plans and are pleased to have found such a partner in Ombu."

####

For more information, please click here

Contacts:
Ombu
Stephen Brooke
CEO
Tel: + 44 (0) 20 7752 0865
Tavistock Communications
John West / Teresa Towner
Tel: +44 (0)20 7920 3150

Copyright © Ombu Group

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Evidence mounts for quantum criticality theory: Findings bolster theory that quantum fluctuations drive strange electronic phenomena January 30th, 2015

Everything You Need To Know About Nanopesticides January 30th, 2015

DNA nanoswitches reveal how life's molecules connect: An accessible new way to study molecular interactions could lower cost and time associated with discovering new drugs January 30th, 2015

Crystal light: New light-converting materials point to cheaper, more efficient solar power: University of Toronto engineers study first single crystal perovskites for new solar cell and LED applications January 30th, 2015

Park Systems Announces Innovations in Bio Cell Analysis with the Launch of Park NX-Bio, the only 3-in-1 Imaging Nanoscale Tool Available for Life Science Researchers January 29th, 2015

Imaging

Park Systems Announces Innovations in Bio Cell Analysis with the Launch of Park NX-Bio, the only 3-in-1 Imaging Nanoscale Tool Available for Life Science Researchers January 29th, 2015

2015 Nanonics Image Contest January 29th, 2015

JPK opens new expanded offices in Berlin to meet the growing demand for products worldwide January 28th, 2015

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Ref signals deep impact as EPSRC announces £30 million for impact acceleration accounts (IAA) January 21st, 2015

Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015

QD Vision Receives New Funding Round to Meet Growing Demand for Quantum Dot Technology: Industry Veteran Steve Ward Named Executive Chairman January 5th, 2015

Pixelligent Closes $5.5 Million in Funding: Capital Will Be Used to Support Global Customer Growth December 12th, 2014

Investments/IPO's/Splits

Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015

Aspen Aerogels, Inc. to Present at the Needham Growth Conference January 8th, 2015

Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015

Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015

Announcements

Evidence mounts for quantum criticality theory: Findings bolster theory that quantum fluctuations drive strange electronic phenomena January 30th, 2015

Everything You Need To Know About Nanopesticides January 30th, 2015

DNA nanoswitches reveal how life's molecules connect: An accessible new way to study molecular interactions could lower cost and time associated with discovering new drugs January 30th, 2015

Crystal light: New light-converting materials point to cheaper, more efficient solar power: University of Toronto engineers study first single crystal perovskites for new solar cell and LED applications January 30th, 2015

Tools

Hiden Gas Analysers at PITTCON 2015 | Visit us on Booth No. 1127 January 29th, 2015

Advantest to Exhibit at SEMICON Korea in Seoul, South Korea February 4-6 Showcasing Broad Portfolio of Semiconductor Products, Technologies and Solutions January 29th, 2015

Park Systems Announces Innovations in Bio Cell Analysis with the Launch of Park NX-Bio, the only 3-in-1 Imaging Nanoscale Tool Available for Life Science Researchers January 29th, 2015

2015 Nanonics Image Contest January 29th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE